CONSULTANT AGREEMENT
Exhibit
10.2
This
agreement (the “Agreement”) is entered into as of February 1, 2006 by and
between, Xx. Xxxxxxx X Xxxxxx, an individual residing at 000 Xxxxxxxx Xxxxxx,
Xxxxxxxxx 00X, Xxxxxx, XX 00000, (the “Consultant”) and GlycoGenesys, Inc., a
Nevada corporation (the “Company”).
WHEREAS,
the Consultant is in the business of providing the type of services to be
provided under this Agreement, such services being outside the usual course
of
the Company’s business; and
WHEREAS,
the Company desires to have Consultant exercise his independent judgment in
the
provisions of the services to be provided under this Agreement; and
WHEREAS,
subject to execution of this Agreement by the Consultant and the Company, the
Consultant has been designated by the Company to be a consultant to the Company
and to serve in such capacity until the earlier of (i) expiration of the Term
(as defined below); and (ii) his earlier removal, resignation, incapacity or
death; and
WHEREAS,
it is a condition to the Consultant’s assuming the position of Consultant that
he, and the Company, execute and deliver this Agreement, in order to delineate
the general scope of his duties, to ensure the confidentiality of information
presented to the Consultant and to protect the relationship of the Company
with
its employees and customers.
NOW
THEREFORE, in consideration of the foregoing premises, and the mutual covenants
contained herein, and for other good and valuable consideration, the receipt
and
sufficiency of which are hereby acknowledged, the parties hereto agree as
follows:
1. CONSULTANT.
The
Company hereby engages the Consultant to provide services on a full-time basis
for a period effective from the date hereof through the earlier of (a) the
Consultant’s death or the Company’s CEO’s good faith determination that the
Consultant is incapacitated and (b) the termination of this Agreement by the
Company or the Consultant, in either case upon 7 days prior written notice
for
any reason or no reason (that period of time which Consultant serves as a
consultant to the Company, pursuant to the foregoing provisions, hereinafter
referred to as the “Term”). In connection with his consulting duties to the
Company and during the Term, the Consultant agrees to provide requested advice,
input and services regarding analytics, manufacturing, clinical studies and
such
other services as described in, but not limited to, Exhibit
A,
which
may be amended from time to time upon agreement of the Company and the
Consultant.
2. COMPENSATION
AND REIMBURSEMENTS.
In
consideration hereto, and in consideration of the Consultant’s agreement to
serve as a Consultant to the Company, the Company:
(a) shall
pay
the Consultant at the rate of $14,000 per month for consulting services,
including such pro rata amounts for such partial months in which services are
provided; and
(b) shall
pay
the Consultant’s travel expenses if necessary to perform consulting services
provided said expenses are pre-approved by the Company’s CEO; and
(c) shall
pay
the cost of the Consultant’s health insurance coverage during the Term, such
coverage to be provided through the Company’s health insurance plan through what
is known as “mini-COBRA”.
The
Consultant shall be available to provide services to the Company on a full-time
basis. Payment to Consultant shall be made upon the receipt by the Company
of an
invoice from Consultant. Upon termination of this agreement pursuant to Section
1, the Company shall pay Consultant all sums owing under this Section 2 through
the date of termination.
3. CONFIDENTIALITY.
(a) Company
Information.
The
Consultant and the Company have executed a confidentiality agreement dated
February 1, 2006 (the “Confidentiality Agreement”) to protect the Company’s
interests and rights concerning its confidential and/or proprietary information.
Such confidentiality agreement is made a part of this Agreement. All equipment,
materials, documents, data, information and suggestions of every kind and
description supplied to the Consultant directly or indirectly by the Company
or
prepared or developed by the Consultant pursuant to this Agreement (except
for
the Consultant’s procedural manuals, personnel data, and Consultant developed
computer software), or resulting from the services provided hereunder shall
be
the sole and exclusive property of the Company and be treated as Confidential
Information (pursuant to this Section 3(a)). The Company shall have the right
to
make whatever use it deems desirable of any such materials, documents, data
and
information.
(b) Current
and Former Employer Information.
The
Consultant agrees that, during the Term, he will not improperly use or disclose
any confidential or proprietary information or trade secrets of any current
or
former employers or companies, if any, and he will not bring onto the premises
of the Company any unpublished documents or property belonging to any current
or
former employers or companies, unless: (i) consented to in writing by said
employers or companies; and (ii) a copy of such written consent is transmitted
to the Company’s CEO prior to any such use or disclosure otherwise prohibited by
this Section 3(b).
(c) Third
Party Information.
The
Consultant acknowledges that the Company has received and in the future will
receive from third parties their confidential or proprietary information subject
to a duty on the Company’s part to maintain the confidentiality of such
information and, in some cases, to use it only for certain limited purposes.
The
Consultant agrees that he owes the Company and such third parties, both during
the Term and thereafter, a duty to hold all such third-party confidential or
proprietary information in the strictest confidence and not to disclose it
to
any person, firm or corporation (except in a manner that is consistent with
the
Company’s agreement with the third party) or use it for the benefit of anyone
other than the Company or such third party (consistent with the Company’s
agreement with the third party), unless expressly authorized in writing to
act
otherwise by an officer of the Company.
4. NON-SOLICITATION.
The
Consultant, during the Term and for a period ending one (1) year after the
date
hereof, shall not directly or indirectly, solicit or encourage any employee
or
any other person or entity who is a customer or supplier of the Company to
terminate, or otherwise interfere in, its then-current relationship with the
Company.
5. INVENTIONS
AND ORIGINAL WORKS.
The
Consultant shall disclose promptly to the Company any and all conceptions and
ideas for inventions, improvements, discoveries and works, whether or not
patentable or copyrightable, which are made, conceived, invented, discovered,
originated, authored, created, learned or reduced to practice by the Consultant,
either alone or together with others, in the course of performing his duties
and
responsibilities hereunder or in the course of otherwise rendering any services
to the Company or which arise out of or are based upon any Confidential
Information (as such term is defined in the Confidentiality Agreement)
(collectively, “Proprietary Rights”) and the Consultant hereby assigns and
agrees to assign all his interests therein to the Company or its
nominee.
Upon
the
request of the Company and at the Company’s sole expense, discretion and
exclusive control, the Consultant shall apply, or assist and cooperate with
Company in applying for, patents or other legal protections for any such
inventions and discoveries in the United States and all foreign countries (and
for any extension, continuation, validation, reissue or renewal thereof). The
Consultant agrees to execute all papers necessary therefor, including
assignments to the Company or its nominee, without consideration, and also
agree
without further consideration, to provide such information as may be required
by
the Company and to assist the Company, or its designees, in the preparation
and
prosecution of any such invention or discovery.
The
Consultant hereby irrevocably appoints the Company as the Consultant’s
attorney-in-fact for the purpose of executing the documents in the Consultant’s
name as may be necessary or desirable to carry out the purposes of this Section
5.
6. RETURN
OF COMPANY DOCUMENTS.
The
Consultant agrees that upon expiration of the Term, for whatever reason, he
will
deliver to the Company and will not keep in his possession, or recreate or
deliver to anyone else, any and all devices, records, data, notes, reports,
proposals, lists, correspondence, specifications, drawings, blueprints,
sketches, materials, other documents or property, together with all copies
thereof (in whatever form or media) belonging to the Company, its successors
or
assigns or relating to the Confidential Information; provided that the
Consultant may keep a single copy of Confidential Information pursuant to
Section 5 of the Confidentiality Agreement.
7. NOTIFICATION.
The
Consultant hereby consents to the Company’s notification, during and at anytime
after the expiration of the Term, of any employer or other applicable third
party of his rights and obligations under this Agreement.
8. LEGAL
AND EQUITABLE REMEDIES.
(a) The
Consultant acknowledges and agrees that the Company would be damaged irreparably
in the event any of the provisions of this Agreement are not performed in
accordance with their specific terms or otherwise are breached. Accordingly,
the
Consultant agrees that the Company shall be entitled to an injunction or
injunctions to prevent breaches of the provisions of this Agreement and to
enforce specifically this Agreement and the terms and provisions hereof in
any
action instituted in any court of the United States or any state thereof having
jurisdiction over the parties hereto and the subject matter hereof, in addition
to any other remedy to which it may be entitled, at law or in
equity.
(b) The
Company shall indemnify the Consultant for any and all damages, costs, expenses,
and other liabilities, including reasonable attorney’s fees and court costs,
incurred in connection with any third-party claim, action or proceeding, arising
from any breach by the Company, its directors, officers, employees, agents
or
representatives, of any of its obligations hereunder, provided, however, that
the Company shall have no obligation hereunder with respect to any claim, action
or proceeding to the extent arising from the negligence or willful misconduct
of
the Consultant or the breach by the Consultant of any of his obligations under
this Agreement. In no event shall the Company’s obligation to indemnify the
Consultant be greater than the amount paid and/or due to the Consultant by
the
Company under this Agreement as of the date of the breach giving rise to such
indemnification obligation.
9. RELATIONSHIP
TO THE COMPANY.
The
Consultant is retained only for the purposes and to the extent set forth in
this
Agreement and it is expressly understood and agreed by the Consultant and the
Company that the Consultant shall serve the Company solely as an independent
contractor and not as an employee. The Consultant shall perform the services
hereunder independent from the Company’s supervisory direction or control. The
Consultant shall not have any authority to enter into agreements or commitments
on behalf of the Company, except as expressly set forth in a writing executed
and delivered by the CEO of the Company, and the Consultant shall not be
entitled to receive any payments from the Company by way of compensation,
expenses, reimbursements or otherwise, except for the compensation and
reimbursements to be paid by the Company as set forth in Section 2 above.
Nothing contained herein shall be construed as making the Consultant an
affiliate, owner or employee of the Company.
10. PUBLICITY.
The
Consultant will not originate any publicity, news release or other public
announcement, written or oral, relating to this Agreement without the Company’s
prior written consent. Neither the Consultant’s name nor that of the Company
will be used in any advertising, promotional or sales literature, or other
publicity without the prior written approval of the party whose name is to
be
used; provided, however, that the Consultant hereby consents to the use of
the
Consultant’s name and to any other disclosure relating to the Consultant’s
relationship with the Company or of any agreements between the Consultant and
the Company in any filing or other document to the extent reasonably required
by
securities law.
11. TERMINATION.
Subject
to the provisions of Section 12 below, this Agreement shall terminate upon
expiration of the Term.
12. SURVIVAL.
(a) All
terms
of this Agreement shall survive the assignment of this Agreement by the Company
to any successor in interest or other assignee.
(b) The
obligations of the Consultant under Sections 3, 4, 5, 6 and 10, the rights
of
the Company under Sections 5, 7, 8 and 10, and the provisions of this Section
12, shall survive the termination or expiration of this Agreement.
13. MISCELLANEOUS.
(a) Notices.
All
notices required or permitted under this Agreement shall be in writing and
shall
be addressed to the other party at the address set forth below or at such other
address or addresses as either party shall designate to the other in accordance
with this Section 13(a). All notices shall be sent by registered or certified
mail, return receipt requested or by Federal Express or other comparable courier
providing proof of delivery and shall be deemed date given and received (i)
if
mailed, on the third business day following the mailing thereof, or (ii) if
sent
by courier, the date of its receipt.
If
to the Company:
|
GlycoGenesys, Inc.
00
Xx. Xxxxx Xxxxxx, 0xx
Xxxxx
Xxxxxx,
XX 00000
Attn:
Xxxx X. Xxxxx
|
If
to the Consultant:
|
Xxxxxxx X Xxxxxx
000
Xxxxxxxx Xxxxxx, Xxxxxxxxx 00X
Xxxxxx,
XX 00000
|
(b) Governing
Law; Consent to Personal Jurisdiction.
This
Agreement will be governed by and construed according to the internal laws
of
The Commonwealth of Massachusetts, without regard to the conflicts of law
principal thereof. The Consultant hereby expressly consents to the personal
jurisdiction of the state and federal courts located in Massachusetts for any
lawsuit filed in such court against the Consultant by the Company arising from
or relating to this Agreement.
(c) Entire
Agreement.
This
Agreement sets forth the final, complete and exclusive agreement and
understanding between the Company and the Consultant relating to the subject
matter hereof and supersedes all prior and contemporaneous understandings and
agreements relating to its subject matter other than the Confidentiality
Agreement between the Consultant and the Company referenced in Section 3(a).
No
modification of or amendment to this Agreement, nor any waiver of any rights
under this Agreement, will be effective unless in writing signed by each of
the
parties hereto.
(d) Severability.
Any
term or provision of this Agreement that is invalid or unenforceable in any
situation in any jurisdiction shall not affect the validity or enforceability
of
the remaining terms and provisions hereof or the validity or enforceability
of
the offending term or provision in any other situation or in any other
jurisdiction.
(e) Successors
and Assigns.
This
Agreement will be binding upon the Consultant’s heirs, executors, administrators
and other legal representatives and will be for the benefit of the Company,
its
successors and its assigns.
(f) Waiver.
No
waiver by the Company of any breach of this Agreement shall be a waiver of
any
preceding or succeeding breach. No waiver by the Company of any right under
this
Agreement shall be construed as a waiver of any other right. The Company shall
not be required to give notice to enforce strict adherence to all terms of
this
Agreement.
(g) Understand
Entire Agreement.
THE
CONSULTANT REPRESENTS AND WARRANTS THAT HE HAS READ AND UNDERSTANDS EACH AND
EVERY PROVISION OF THIS AGREEMENT AND FURTHER UNDERSTANDS THAT HE IS FREE TO
OBTAIN ADVICE FROM LEGAL COUNSEL OF HIS CHOICE, IF DESIRED, IN ORDER TO
INTERPRET ANY AND ALL PROVISIONS OF THIS AGREEMENT AND HAS FREELY AND
VOLUNTARILY ENTERED INTO THIS AGREEMENT.
IN
WITNESS WHEREOF, the parties hereto have executed, or caused to be executed,
this Agreement as of the date first above written.
THE CONSULTANT: |
THE
COMPANY:
GLYCOGENESYS,
INC.
|
|
|
|
|
/s/ Xxxxxxx X Xxxxxx | By: | /s/ Xxxx X. Xxxxx |
Name: Xxxxxxx X Xxxxxx |
Name: Xxxx X. Xxxxx |
|
Title: Senior Vice President and CFO |
EXHIBIT
A
Services
Xx. Xxxxxx will perform for GlycoGenesys:
·
|
Assistance
with transitional issues associated with management
changes.
|
·
|
Assistance
with clinical trials, relationships with SAB members and site
doctors.
|
·
|
Assistance
with manufacturing and production of
GCS-100.
|
·
|
Provide
advice regarding development of
GCS-100.
|
·
|
Provide
assistance regarding outstanding litigation, including participation
in
meetings and depositions and providing
affidavits.
|